March 19, 2018 by Geoff Walden and Chain Drug Review
Albertsons Cos., Albertsons-Rite Aid merger, Bob Miller, Diana Sheehan, John Standley, Kantar Consulting, Kermit Crawford, Rite Aid
2018, Issue 03-19-2018, Issues, News
CAMP HILL, Pa. — The merger of Albertsons Cos. and Rite Aid Corp. will create a “truly differentiated” player in the food, health and wellness space, John Standley, chairman and chief executive officer of Rite Aid, said when the deal was announced late last month. The proposed merger will transform Rite Aid through the addition
February 26, 2018 by Geoff Walden and Chain Drug Review
Affordable Care Act, Avalere, CHRONIC Act, CREATES Act, Daniel Mendelson, federal budget legislation, health care spending, Independent Payment Advisory Board, Medicare Part D, Pharmaceutical Research and Manufacturers of America, Stephen Ubl
2018, Issue 02-26-2018, Issues, Leading Headlines, News, Pharmacy, Retail News
WASHINGTON — Health care spending has been beefed up in some areas and reduced in others as a result of the federal budget legislation passed by Congress earlier this month. Chronic care funding was bolstered by the two-year spending plan, which was signed into law by President Trump, while some Affordable Care Act appropriations were
February 20, 2018 by Jeffrey Woldt, Geoff Walden and Chain Drug Review
Albertsons Cos., Albertsons-Rite Aid merger, Bob Miller, John Standley, Kermit Crawford, Rite Aid
Business, Featured Articles, Leading Headlines, Retail News
CAMP HILL, Pa. — The Albertsons Cos. merger with Rite Aid Corp. will create a “truly differentiated” player in the food, health and wellness space, John Standley, chairman and chief executive officer of Rite Aid, said in an interview with Chain Drug Review. The Albertsons-Rite Aid merger deal, announced Tuesday, will transform Rite Aid through
February 12, 2018 by Geoff Walden and Chain Drug Review
Canadian generic drug prices, Canadian Generic Pharmaceutical Association, Canadian Pharmaceutical Alliance, Desjardins Capital Markets, Eric La Flèche, Keith Howlett, Loblaw, lower generic drug prices, Metro Inc., Richard Dufresne, Shoppers Drug Mart
2018, Issue 02-12-2018, Issues, Leading Headlines, News, Pharmacy, Retail News
TORONTO — Pharmacy operators across Canada will be hit hard by lower generic drug prices set to take effect this spring, said Metro Inc. chief executive officer Eric La Fleche. The pan-Canadian Pharmaceutical Alliance — which represents the provincial, territorial and federal governments — and the Canadian Generic Pharmaceutical Association announced late last month that
February 12, 2018 by Geoff Walden and Chain Drug Review
B. Douglas Hoey, Centers for Medicare & Medicaid Services, DIR fees, direct and indirect remuneration fees, NACDS, National Association of Chain Drug Stores, National Community Pharmacists Association, NCPA, PCMA, Pharmaceutical Care Management Association, Steve Anderson
2018, Issue 02-12-2018, Issues, News
ARLINGTON, Va. — The “untenable” procedures around direct and indirect remuneration fees (DIR fees) can be righted with measures reducing costs for beneficiaries and the government, while promoting a more quality-driven health care system, says the National Association of Chain Drug Stores. NACDS expressed that message in comments to the Centers for Medicare & Medicaid
February 8, 2018 by Geoff Walden
CVS Health, CVS Pharmacy, Helena Foulkes, Kevin Hourican
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — Kevin Hourican, executive vice president of retail pharmacy and supply chain at CVS Health, will run the company’s retail division on an interim basis following the departure of Helena Foulkes. As the interim head of CVS Pharmacy, Hourican will report to CVS Health chief operating officer Jon Roberts, the company said Thursday.
January 17, 2018 by Geoff Walden
James Skinner, Stefano Pessina, Walgreens, Walgreens Boots Alliance, Walgreens Boots Alliance annual shareholders meeting
Business, Leading Headlines, Retail News
SCOTTSDALE, Ariz. — Walgreens is halfway through a transformation that includes a rethinking of its supply chain and services, Walgreens Boots Alliance executive vice chairman and CEO Stefano Pessina said at the company’s annual shareholders meeting. Walgreens is also recasting its approach to interacting with customers and patients, Pessina added, noting that 2018 will see
January 15, 2018 by Geoff Walden and Chain Drug Review
AmerisourceBergen, Brian Nightengale, community pharmacy, Elevate Provider Network, Good Neighbor Pharmacy, independent pharmacies, J.D. Power U.S. Pharmacy Study
2018, Featured Articles, Issue 01-15-2018, Issues, Leading Headlines, News, Retail News
VALLEY FORGE, Pa. — AmerisourceBergen Corp.’s backing, combined with the entrepreneurship of independent pharmacies, has made the company’s Good Neighbor Pharmacy network an exemplar of high-touch service, says senior vice president of community and specialty pharmacy and Good Neighbor Pharmacy president Brian Nightengale. AmerisourceBergen’s support tools and personnel enhance the inherent ability of independents to
January 15, 2018 by Geoff Walden and Chain Drug Review
ACA open enrollment, Affordable Care Act, health insurance, Lindsey Graham, Mitch McConnell
2018, Issue 01-15-2018, Issues, News
WASHINGTON — Nearly 9 million people signed up for health insurance in the Affordable Care Act’s latest open enrollment period, despite the Trump administration having cut its duration in half. The 8.8 million enrollees were only slightly fewer than the total in the last ACA open enrollment period, which, besides being longer, was much more
January 1, 2018 by Geoff Walden and Chain Drug Review
chain drug store holiday sales, Heather Hughes, holiday retail sales, Jack Kleinhenz, National Retail Federation, Phil Rist, Prosper, Walgreens
2018, Issue 01-01-2018, Issues, News
NEW YORK — Chain drug store holiday sales bettered last year’s results, with total dollar volume rising more than 4% and same-store sales advancing 1.8%. In comparison to the 2016 holiday retail sales season, when anxiety over the new administration may have peaked, consumer confidence was up this year, propelled by income gains and the
December 12, 2017 by Geoff Walden
Gary Senecal, Jeff Leger, Loblaw, Mike Motz, Robert Wiebe, Shoppers Drug Mart
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News
TORONTO — Jeff Leger has been named president of Shoppers Drug Mart, succeeding Mike Motz, who has been promoted to chief operating officer of SDM parent Loblaw Cos. Loblaw confirmed Leger’s appointment on Tuesday. He previously served as executive vice president of pharmacy and health care for both Loblaw and Shoppers Drug Mart stores. Prior
December 11, 2017 by Geoff Walden and Chain Drug Review
John Standley, Rite Aid, Stefano Pessina, Walgreens, Walgreens-Rite Aid merger
2017, Issue 12-11-2017, Issues, News
CAMP HILL, Pa. — Walgreens Boots Alliance has taken over the first 97 of its acquired Rite Aid Corp. stores. WBA purchased 1,932 stores under a revised deal with Rite Aid after the government thwarted its acquisition of the entire chain. WBA also picked up three distribution centers and related inventory from Rite Aid as
December 11, 2017 by Geoff Walden and Chain Drug Review
Adam Fein, Amazon, Amazon and Pharmacy Retail, Amazon's U.S. Pharmacy Opportunity, Charles Rhyee, Cowen, Fung Global Retail & Technology, Pembroke Consulting
2017, Business, Issue 12-11-2017, Issues, Leading Headlines, News, Retail News
NEW YORK — While rumors of Amazon’s entry into pharmacy continue to swirl, some analysts are questioning just how significant the move would be. “Amazon’s U.S. Pharmacy Opportunity: Not Necessarily A Game Changer,” is the title of a report by Cowen. For its part, Fung Global Retail & Technology said the online retailer’s pursuit of
December 5, 2017 by Geoff Walden and Chain Drug Review
ACA, Affordable Care Act, individual mandate, John Barrasso, Mitch McConnell, Senate tax reform bill, Susan Collins
Issue 12-11-2017, News, Pharmacy, Retail News
WASHINGTON — The Senate’s repeal of the Affordable Care Act (ACA) individual mandate as part of its sweeping tax reform bill has likely spelled doom for the provision, which required people who didn’t obtain health insurance to pay a tax penalty. Sen. John Barrasso (R., Wyo.) said the 51-49 vote passing the Senate tax reform